Article info

Download PDFPDF
Treatment-refractory warts associated with fingolimod

Authors

  • Nitin Sahi Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK PubMed articlesGoogle scholar articles
  • Sarmad A Al-Araji Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK PubMed articlesGoogle scholar articles
  • Olga Ciccarelli Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK PubMed articlesGoogle scholar articles
  • Declan T Chard Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK University College London Hospitals (UCLH) Biomedical Research Centre, National Institute for Health Research (NIHR), London, UK PubMed articlesGoogle scholar articles
  • S Anand Trip Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK University College London Hospitals (UCLH) Biomedical Research Centre, National Institute for Health Research (NIHR), London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nitin Sahi, Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK; n.sahi{at}nhs.net
View Full Text

Citation

Sahi N, Al-Araji SA, Ciccarelli O, et al
Treatment-refractory warts associated with fingolimod

Publication history

  • Accepted July 18, 2022
  • First published August 18, 2022.
Online issue publication 
November 30, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Other content recommended for you